| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.552 | 10.831 | 9.524 | 12.388 | 12.500 | 14.547 | 13.525 | 8.547 | 19.133 |
| Total Income - EUR | - | 4.554 | 10.837 | 9.524 | 12.388 | 12.500 | 14.547 | 13.525 | 8.547 | 19.133 |
| Total Expenses - EUR | - | 4.808 | 10.625 | 10.742 | 11.230 | 8.505 | 8.808 | 9.143 | 9.450 | 15.676 |
| Gross Profit/Loss - EUR | - | -254 | 213 | -1.218 | 1.157 | 3.995 | 5.739 | 4.382 | -903 | 3.458 |
| Net Profit/Loss - EUR | - | -345 | 19 | -1.504 | 785 | 3.639 | 5.302 | 3.984 | -903 | 2.932 |
| Employees | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Senevi Medi Test Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 1.300 | 752 | 1.065 | 1.373 | 4.514 | 7.155 | 6.139 | 3.325 | 9.434 |
| Inventories | - | 63 | 0 | 429 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 187 | 423 | 668 | 441 | 1.299 | 1.482 | 4.052 |
| Cash | - | 1.238 | 752 | 449 | 950 | 3.846 | 6.714 | 4.840 | 1.843 | 5.382 |
| Shareholders Funds | - | -301 | -276 | -1.775 | -955 | 2.702 | 5.351 | 4.033 | 1.469 | 2.980 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.701 | 1.028 | 2.840 | 2.328 | 1.812 | 1.804 | 2.106 | 1.856 | 6.454 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8552 - 8552" | |||||||||
| CAEN Financial Year |
8552
|
|||||||||
Comments - Senevi Medi Test Srl